Health Trials

About this trial

The study will evaluate the performance, clinical benefits and safety of the Persona Revision Knee System in patients who have received primary or revision total knee arthroplasty (TKA) treatment. This will be done using a multicenter, single-arm, consecutive series, retrospective cohort study with prospective follow-up.

Eligibility criteria

Qualifiers

Male or female of at least 18 years of age at the time of screening.

Signed an institutional review board approved informed consent.

Willingness and ability to comply with the study procedures and visit schedules and ability to understand and follow oral and written post-operative care instructions.

Rheumatoid arthritis, osteoarthritis, traumatic arthritis or polyarthritis

Disqualifiers

An ulcer of the skin

History of recurrent breakdown of the skin

Use of steroids

Trial design

Treatments tested in this trial

  • Persona Revision Knee System

Treatment groups

380 Participants
are divided into 11 treatment groups

11

Treatment groups

See each treatment group below.

Locations

16
Arkansas
Advanced Orthopaedic Specialists72703, Fayetteville United States
Bowen Hefley Orthopedics72205, Little Rock United States
California
Community Foundation Medical Group93720, Fresno United States
Colorado
Cornerstone Orthopaedics & Sports Medicine80027, Superior United States

Sponsors and collaborators

Zimmer Biomet

Lead sponsor

Source ClinicalTrials.gov